Porton Pharma Collaborates with Henan Hualong for MATC Therapy Development
CompanyDeals

Porton Pharma Collaborates with Henan Hualong for MATC Therapy Development

Bayer Reports Flat Q1 Revenue amid Crop Science Decline
Company

Bayer Reports Flat Q1 Revenue amid Crop Science Decline

Medilink Therapeutics Gains FDA IND Approval for VEGF-Targeted ADC YL242
CompanyDrug

Medilink Therapeutics Gains FDA IND Approval for VEGF-Targeted ADC YL242

Zhongsheng Pharma's Anruiwei Shows Promising Results in Pediatric Influenza A Study
CompanyDrug

Zhongsheng Pharma’s Anruiwei Shows Promising Results in Pediatric Influenza A Study

Sinovac Biotech Gains Hong Kong Approval for Influenza Vaccines
CompanyDrug

Sinovac Biotech Gains Hong Kong Approval for Influenza Vaccines

InnoCare Pharma Reports 129.92% Revenue Surge in Q1 2025, Turns Profitable
Company

InnoCare Pharma Reports 129.92% Revenue Surge in Q1 2025, Turns Profitable

NMPA Releases 92nd Batch of Reference Drugs for Generic Quality Evaluation
DrugPolicy / Regulatory

NMPA Releases 92nd Batch of Reference Drugs for Generic Quality Evaluation

Gan & Lee Pharmaceuticals Signs PDP Agreement with Brazilian Health Ministry
CompanyDeals

Gan & Lee Pharmaceuticals Signs PDP Agreement with Brazilian Health Ministry

Zelgen Biopharmaceuticals Submits New Indication Application for Jacktinib in Severe Alopecia Areata
CompanyDrug

Zelgen Biopharmaceuticals Submits New Indication Application for Jacktinib in Severe Alopecia Areata

Meheco Acquires Golden Harvest for E-commerce Expansion
CompanyDeals

Meheco Acquires Golden Harvest for E-commerce Expansion

JD Healthcare Reports 25.5% Revenue Growth in Q1 2025
Company

JD Healthcare Reports 25.5% Revenue Growth in Q1 2025

Ocumension Therapeutics Receives Approval for OT-703 Real-World Study in China
CompanyDrug

Ocumension Therapeutics Receives Approval for OT-703 Real-World Study in China